- Home
- KTF vs ABEO Comparison
KTF vs ABEO Comparison
Compare KTF & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- ABEO
- Stock Information
- Founded
- KTF 1988
- ABEO 1974
- Country
- KTF United States
- ABEO United States
- Employees
- KTF N/A
- ABEO N/A
- Industry
- KTF Finance Companies
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- ABEO Health Care
- Exchange
- KTF Nasdaq
- ABEO Nasdaq
- Market Cap
- KTF 337.7M
- ABEO 350.2M
- IPO Year
- KTF N/A
- ABEO 1980
- Fundamental
- Price
- KTF $9.26
- ABEO $5.66
- Analyst Decision
- KTF
- ABEO Strong Buy
- Analyst Count
- KTF 0
- ABEO 6
- Target Price
- KTF N/A
- ABEO $18.17
- AVG Volume (30 Days)
- KTF 103.3K
- ABEO 714.3K
- Earning Date
- KTF 01-01-0001
- ABEO 11-13-2025
- Dividend Yield
- KTF 3.54%
- ABEO N/A
- EPS Growth
- KTF N/A
- ABEO N/A
- EPS
- KTF 0.39
- ABEO 0.99
- Revenue
- KTF N/A
- ABEO $400,000.00
- Revenue This Year
- KTF N/A
- ABEO N/A
- Revenue Next Year
- KTF N/A
- ABEO $324.71
- P/E Ratio
- KTF $23.10
- ABEO $5.80
- Revenue Growth
- KTF N/A
- ABEO N/A
- 52 Week Low
- KTF $7.40
- ABEO $3.93
- 52 Week High
- KTF $9.12
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- KTF 52.79
- ABEO 30.19
- Support Level
- KTF N/A
- ABEO $6.53
- Resistance Level
- KTF $9.30
- ABEO $6.95
- Average True Range (ATR)
- KTF 0.08
- ABEO 0.29
- MACD
- KTF -0.29
- ABEO -0.15
- Stochastic Oscillator
- KTF 99.26
- ABEO 1.29
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.